SE
Strategic Education, Inc. (STRA)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 delivered modest top-line growth with consolidated revenue up 2.9% year over year to $321.5M, while operating margin expanded to 14.2% (15.2% on a constant currency, adjusted basis), supported by outsized strength in Education Technology Services (ETS) .
- EPS outperformed Street expectations: adjusted diluted EPS came in at $1.52 versus consensus of ~$1.43; revenue was slightly below consensus ($321.5M vs ~$322.8M). EPS beat was driven by disciplined OpEx and mix shift to ETS, which posted 50% YoY revenue and operating income growth . Estimates with * retrieved from S&P Global.
- USHE exhibited mixed dynamics: healthcare portfolio enrollment rose 8% and employer-affiliated reached a new high of 31.8% of enrollment, but unaffiliated enrollment remained a headwind; ANZ revenue declined on regulatory pressure to international enrollments, partially offset by domestic strength .
- Capital allocation remains active: quarterly dividend of $0.60/share and $28M in Q2 buybacks ($60M YTD), with ~$169M remaining under the repurchase authorization through year-end .
- Near-term stock catalysts: ETS scaling (Sophia +40% revenue to $16.4M; Workforce Edge now at 80 corporate agreements) and potential policy tailwinds from the employer tuition assistance cap increase mentioned on the call; watch for ANZ regulatory normalization and domestic marketing ramp .
What Went Well and What Went Wrong
What Went Well
- ETS momentum and mix shift: “ETS revenue and operating income both increased 50%… to $37 million and $15 million, respectively,” with stable ~41% operating margin despite investment; Sophia subscribers and revenue grew ~40% YoY; Workforce Edge at 80 corporate partners covering ~3.87M employees .
- Margin execution: Operating margin expanded to 14.2% GAAP and 15.2% adjusted constant currency; adjusted operating income rose to $49.1M (from $43.9M) on disciplined expense growth (~2%) .
- USHE healthcare portfolio strength: Total enrollment in healthcare programs rose 8% and now represents 47% of USHE enrollment vs 43% a year ago; employer-affiliated share hit 31.8% (new high) as corporate partnerships deepen .
What Went Wrong
- USHE unaffiliated softness at Strayer: Management flagged ongoing pressure in unaffiliated undergraduate enrollment at Strayer, though “the rate of decline was slightly better in Q2 than Q1,” leaving total USHE enrollment down 0.8% YoY .
- ANZ regulatory headwinds: International enrollment declines (indicative caps and visa velocity constraints) weighed on ANZ revenue (-2.8% YoY), though domestic growth is improving; management expects to lap declines early 2026 .
- Top-line vs consensus: Revenue was modestly below the Street in Q2 ($321.5M actual vs ~$322.8M consensus*), reflecting USHE enrollment declines and ANZ constraints despite ETS strength . Estimates with * retrieved from S&P Global.
Financial Results
Consolidated Results (GAAP and Adjusted)
Segment Breakdown (Q2 YoY)
KPIs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “On a constant currency basis, SEI's revenue grew 4%… expense growth limited to 2%, resulting in operating income of $49 million… operating margin increased 110 bps to 15.2%… Adjusted EPS were $1.54 vs $1.33” .
- “ETS revenue and operating income both increased 50%… Sophia… grew both average and total subscribers and revenue by 40%… Workforce Edge… now has 80 total corporate partnerships… more than 3.8 million employees” .
- “U.S. higher education total enrollment decreased by 1%… employer-affiliated enrollment increased by 8% and now represents 32% of all U.S. higher education enrollment… healthcare portfolio… increased its total enrollment by 8%” .
- “ANZ… decreased 3%… driven by… restrictions on international student enrollment… optimistic about pivot to domestic market… planning to increase marketing investments in the back half” .
Q&A Highlights
- USHE unaffiliated enrollment: softness concentrated at Strayer undergrad; decline rate “slightly better” in Q2 vs Q1; management expects normalization over time .
- ANZ split and outlook: composition skewing more domestic; declines in both offshore visa-driven and onshore transfer pathways; expects to lap international declines early 2026; ramping domestic marketing in H2 2025 .
- ETS large employer onboarding: ramp progressing well; significant revenue contribution expected through back half as employees migrate to the platform .
- Policy environment: “One Big Beautiful Bill” not expected to be materially adverse; employer tuition assistance cap increase and potential workforce Pell inclusion viewed as positives .
Estimates Context
Results vs Wall Street consensus (S&P Global):
Estimates with * retrieved from S&P Global.
Interpretation:
- Q2 2025: EPS beat driven by margin expansion and ETS mix; slight revenue miss reflects USHE unaffiliated softness and ANZ regulatory headwinds despite strong ETS growth .
- Estimate trajectory: Company has consistently outperformed EPS consensus in recent quarters while revenue outcomes have been mixed, suggesting upside from operating leverage and portfolio mix even amid enrollment variability .
Key Takeaways for Investors
- ETS is becoming a larger earnings driver (31% of SEI operating income vs 23% last year), with durable 41% operating margins, Sophia +40% growth, and Workforce Edge scaling to 80 partners—supporting a structurally higher margin profile .
- USHE mix shift toward employer-affiliated and healthcare programs (47% of USHE enrollment) improves revenue quality and persistence even as unaffiliated enrollment cycles; monitor Strayer unaffiliated stabilization in H2 .
- ANZ near-term revenue softness is policy-driven; management plans to fully fund domestic marketing in H2 2025 and expects growth resumption post-lap in early 2026—watch for domestic intake momentum .
- EPS beats alongside mixed revenue prints highlight cost control and margin execution; adjusted EPS ($1.52) materially above GAAP ($1.37) given restructuring/investment mark-to-market and tax adjustments—focus on non-GAAP drivers in modeling .
- Capital returns remain active (dividend maintained at $0.60; $60M YTD buybacks; ~$169M authorization remaining), offering downside support while ETS scales .
- Policy developments: employer tuition assistance cap increase and possible workforce Pell inclusion could be incremental positives for employer-affiliated enrollment and ETS offerings .
- Near-term trading setup: positive EPS surprise and ETS momentum are supportive; headline risk remains around ANZ regulatory actions and USHE unaffiliated trends—focus on upcoming Q3 cadence and any update on ETS large-partner ramp .